These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 9253035

  • 1. Expression of the antiapoptotic protein bcl-2 is not dependent on the tumor suppressor p53 protein in Indian breast carcinoma.
    Kesari AL, Chellam VG, Madhavan J, Nair PP, Nair MK, Pillai MR.
    Pathobiology; 1997; 65(2):108-12. PubMed ID: 9253035
    [Abstract] [Full Text] [Related]

  • 2. bcl-2 protein expression is associated with a prognostically favourable phenotype in breast cancer irrespective of p53 immunostaining.
    Nakopoulou L, Michalopoulou A, Giannopoulou I, Tzonou A, Keramopoulos A, Lazaris AC, Davaris PS.
    Histopathology; 1999 Apr; 34(4):310-9. PubMed ID: 10231398
    [Abstract] [Full Text] [Related]

  • 3. Co-expression of p53 and bcl-2 may correlate to the presence of epstein-barr virus genome and the expression of proliferating cell nuclear antigen in nasopharyngeal carcinoma.
    Niemhom S, Kitazawa S, Murao S, Kunachak S, Maeda S.
    Cancer Lett; 2000 Nov 28; 160(2):199-208. PubMed ID: 11053650
    [Abstract] [Full Text] [Related]

  • 4. Spontaneous programmed cell death in infiltrating duct carcinoma: association with p53, BCL-2, hormone receptors and tumor proliferation.
    Pillai MR, Kesari AL, Chellam VG, Madhavan J, Nair P, Nair MK.
    Pathol Res Pract; 1998 Nov 28; 194(8):549-57. PubMed ID: 9779489
    [Abstract] [Full Text] [Related]

  • 5. Expression of bcl-2, c-erbB-2, p53, and p21 (waf1-cip1) protein in thyroid carcinomas.
    Soda G, Antonaci A, Bosco D, Nardoni S, Melis M.
    J Exp Clin Cancer Res; 1999 Sep 28; 18(3):363-7. PubMed ID: 10606183
    [Abstract] [Full Text] [Related]

  • 6. Expression of bcl-2, p53 oncoprotein, and proliferating cell nuclear antigen in renal cell carcinoma.
    Sejima T, Miyagawa I.
    Eur Urol; 1999 Sep 28; 35(3):242-8. PubMed ID: 10072628
    [Abstract] [Full Text] [Related]

  • 7. Immunohistochemical study of apoptosis-related Bcl-2 protein and its correlation with proliferation indices (Ki67, PCNA), tumor suppressor genes (p53, pRb), the oncogene c-erbB-2, sex steroid hormone receptors and other clinicopathological features, in normal, hyperplastic and neoplastic endometrium.
    Mitselou A, Ioachim E, Kitsou E, Vougiouklakis T, Zagorianakou N, Makrydimas G, Stefanaki S, Agnantis NJ.
    In Vivo; 2003 Sep 28; 17(5):469-77. PubMed ID: 14598611
    [Abstract] [Full Text] [Related]

  • 8. bcl-2, p53 and proliferating cell nuclear antigen expression is related to the degree of differentiation in thyroid carcinomas.
    Pollina L, Pacini F, Fontanini G, Vignati S, Bevilacqua G, Basolo F.
    Br J Cancer; 1996 Jan 28; 73(2):139-43. PubMed ID: 8546897
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Bcl-2 and proliferating cell nuclear antigen (PCNA) expression correlates with subsequent local recurrence in nasopharyngeal carcinomas.
    Tsai ST, Jin YT, Leung HW, Wang ST, Tsao CJ, Su IJ.
    Anticancer Res; 1998 Jan 28; 18(4B):2849-54. PubMed ID: 9713473
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The relationship of expression of bcl-2, p53, and proliferating cell nuclear antigen (PCNA) to cell proliferation and apoptosis in renal cell carcinoma.
    Zhu Z, Xing S, Cheng P, Li G, Yang Y, Zeng F, Lu G.
    J Huazhong Univ Sci Technolog Med Sci; 2004 Jan 28; 24(4):354-7. PubMed ID: 15587397
    [Abstract] [Full Text] [Related]

  • 13. p53 tumor suppressor protein and tissue proliferative fraction in infiltrating duct carcinoma.
    Kesari AL, Chellam VG, Nair PP, Ahmed I, Madhavan J, Thomas PA, Nair MK, Pillai MR.
    J Surg Oncol; 1997 Jul 28; 65(3):159-63. PubMed ID: 9236923
    [Abstract] [Full Text] [Related]

  • 14. Epithelial cell turnover, p53 and bcl-2 protein expression during oncogenesis of early and advanced gastric cancer in a Western population.
    Triantafyllou K, Kitsanta P, Karamanolis DG, Kittas C, Ladas SD.
    Dig Liver Dis; 2008 Jan 28; 40(1):39-45. PubMed ID: 18063429
    [Abstract] [Full Text] [Related]

  • 15. Conjugated linoleic acids (CLAs) regulate the expression of key apoptotic genes in human breast cancer cells.
    Majumder B, Wahle KW, Moir S, Schofield A, Choe SN, Farquharson A, Grant I, Heys SD.
    FASEB J; 2002 Sep 28; 16(11):1447-9. PubMed ID: 12205043
    [Abstract] [Full Text] [Related]

  • 16. Of humans and canines: Immunohistochemical analysis of PCNA, Bcl-2, p53, cytokeratin and ER in mammary tumours.
    Kumaraguruparan R, Prathiba D, Nagini S.
    Res Vet Sci; 2006 Oct 28; 81(2):218-24. PubMed ID: 16740286
    [Abstract] [Full Text] [Related]

  • 17. Expression of bax and p53 proteins in the tumorigenesis and progression of breast carcinomas.
    Redondo M, Garcia J, Rodrigo I, Villar E, González C, Morell M.
    Tumour Biol; 2003 Oct 28; 24(1):23-31. PubMed ID: 12743423
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Low expression of bcl-2 in Brca1-associated breast cancers.
    Freneaux P, Stoppa-Lyonnet D, Mouret E, Kambouchner M, Nicolas A, Zafrani B, Vincent-Salomon A, Fourquet A, Magdelenat H, Sastre-Garau X.
    Br J Cancer; 2000 Nov 28; 83(10):1318-22. PubMed ID: 11044356
    [Abstract] [Full Text] [Related]

  • 20. [Regulation of p53 and bcl-2 proteins to apoptosis and cell proliferation in liver cirrhosis and hepatocellular carcinoma].
    Feng D, Zheng H, Shen M, Cheng R, Yan Y.
    Hunan Yi Ke Da Xue Xue Bao; 1999 Nov 28; 24(4):325-8. PubMed ID: 12080637
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.